Market Research Report
Clinical Nutrition Market Size By Product, By Consumer, By Application, By Distribution Channel, Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2021 - 2027
|Clinical Nutrition Market Size By Product, By Consumer, By Application, By Distribution Channel, Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2021 - 2027|
Published: July 2, 2021
Global Market Insights Inc.
Content info: 200 Pages
Delivery time: 2-3 business days
The clinical nutrition market is expected to witness sizable growth by 2027 driven by the increasing prevalence of chronic illnesses around the globe.
Recently, amidst the artificial intelligence (AI) revolution in the medical sector, researchers have been examining the potential integration of AI for food image recognition, augmented diet optimization, diet pattern analysis, and risk prediction, among other applications. Subsequently, technological advancements in the sector are fueling market demand globally.
Additionally, industry players are adopting strategic initiatives to improve their market presence, which has favorably impacted business expansion across key regions. For instance, in June 2021, Guardion Health Sciences, a clinical nutrition and diagnostics firm, announced the acquisition of Adare Pharmaceuticals subsidiary Activ Nutritional as part of its expansion strategy.
For extensive assessment, the clinical nutrition market has been categorized on the basis of product, application, consumer, distribution channel, and region. Based on product, the market has been segregated into enteral nutrition, infant nutrition, and parenteral nutrition.
The parenteral nutrition sub-segment holds a substantial revenue share in the clinical nutrition market and was valued at around USD 5.3 billion in 2020. Increasing prevalence of chronic conditions that cause malnutrition and weight loss, along with growing adoption of parenteral nutrition in healthcare as well as home care settings, is projected to fuel segmental growth through the forecast period.
In terms of consumer, the market has been bifurcated into pediatric and adult. The adult sub-segment was valued at over USD 18.9 billion in 2020 and is estimated to witness significant growth over the analysis period. Surging prevalence of gastrointestinal disorders, such as ulcerative colitis, short bowel syndrome, and bowel obstruction, among the adult population is anticipated to boost segmental adoption in the coming years.
With respect to application, the clinical nutrition market has been divided into cancer, neurological diseases, metabolic disorders, gastrointestinal disorders, and others. The cancer sub-segment accounted for a considerable share of the clinical nutrition market in 2020 and is anticipated to reach a valuation of about USD 12.3 billion by the end of 2027. Rising prevalence of cancer and growing awareness regarding the significance of clinical nutrition in cancer treatment are likely to contribute to segmental expansion over the estimated timeline.
From the perspective of distribution channel, the market has been segmented into pharmacies & drug stores, online channel, retail stores, and others. The online channel sub-segment contributes to a substantial share of the clinical nutrition market and was valued at USD 7.5 billion in 2020. Escalating internet penetration and surging preference for ordering through online channels and e-commerce portals are speculated to boost segmental demand in the future.
In the regional landscape, the Middle East & Africa clinical nutrition market is projected to witness substantial growth to exceed a valuation of USD 3.7 billion by 2027. High number of mortalities related to malnutrition and growing awareness regarding clinical nutrition across the region are expected to foster market outlook through the forecast timeframe.